168 results on '"Perry, Jacqueline"'
Search Results
2. Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study
3. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study
4. Patient Preferences for Intervention in the Setting of Precursor Multiple Myeloma
5. Supplementary Figures and Tables from MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology
6. Data from MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology
7. PTSD symptom profiles among Louisiana women affected by the 2010 Deepwater Horizon Oil Spill: A latent profile analysis
8. P-092 High serum free light chains levels in African ancestry population screened for monoclonal gammopathy: implication for definition of FLC reference range accounting for renal function and race
9. OA-35 High-throughput plasma proteomics to define the precursor multiple myeloma proteome and identify candidate high-risk disease biomarkers of progression
10. P-097 Single-cell RNA sequencing of circulating tumor cells in precursor myeloma patients reveals early mechanisms of disease dissemination
11. Abstract 796: Altered immune response to vaccination in patients with plasma cell premalignancy
12. MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology
13. Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
14. Monitoring Plasma Cells and Clonal Emergence through Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma
15. Single-Cell RNA Sequencing of Rare Circulating Tumor Cells in Precursor Myeloma Patients Reveals Molecular Underpinnings of Tumor Cell Circulation
16. High-Throughput Plasma Proteomic Profiling to Identify Candidate High-Risk Disease Biomarkers in Precursor Multiple Myeloma Patients
17. Single-Cell RNA-Sequencing of 245 Tumor Samples from Patients with MGUS and Smoldering Multiple Myeloma Reveals Novel Insights into Malignant Plasma Cell Biology
18. Dysregulated Humoral and Cellular Response to Sars-Cov-2 Vaccination in Patients with MGUS and SMM
19. In Situ Characterization of Chromatin Landscape in Progression of Smoldering Precursor Stage to Multiple Myeloma
20. Reconstructing the Genomic History of Multiple Myeloma Precursor Disease: Novel Insights and Clinical Applicability
21. Prevalence of Monoclonal Gammopathies Detected By Mass Spectrometry and Their Risk Factors Among Black Africans in South Africa
22. Persistence of Monoclonal Gammopathies in Serial Samples from a US Population-Based Screening Study
23. Abnormal Free Light Chains in Individuals with African Ancestry Screened for Monoclonal Gammopathy: Definition of New Reference Range Accounting for Renal Function and Race
24. P-055: Monitoring the emergence of multiple myeloma high-risk subclones with whole-genome sequencing of circulating tumor cells
25. OAB-036: The PANGEA model: dynamic modeling for personalized prediction of precursor disease progression to multiple myeloma
26. Abstract 3582: Single-cell RNA-sequencing for immune profiling of SARS-CoV2 vaccine response in healthy individuals and patients with precursor plasma cell malignancies
27. Abstract 3651: Obesity, metabolic comorbidities, and lifestyle factors and their association with monoclonal gammopathies in a high-risk screened population: Results of the PROMISE study
28. Abstract 641: Single-cell RNA sequencing of rare circulating tumor cells in precursor myeloma patients reveals molecular underpinnings of tumor cell circulation
29. Abstract 5277: Humoral SARS-CoV-2 response in asymptomatic precursor plasma cell dyscrasia patients: IMPACT study results
30. Abstract 2259: Predictive modeling of smoldering multiple myeloma progression to multiple myeloma by continuous variable analysis
31. Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
32. Mass Spectrometry-Detected Monoclonal Gammopathy of Undetermined Significance is Associated with Obesity and Other Novel Modifiable Risk Factors: Results of the Promise Study
33. High Prevalence of Monoclonal Gammopathy in a Population at Risk: The First Results of the Promise Study
34. Social Determinants of Health and COVID-19 Behaviors and Beliefs Toward Immunizations Among Latinxs
35. P-096 Real world evidence of suboptimal humoral and cellular immune response to vaccination in ostensibly asymptomatic patients with precursor stage of multiple myeloma
36. Prevalence of Monoclonal Gammopathies Including an Age-Related Monoclonal Gammopathy of Indeterminate Potential (MGIP) in a Racially Diverse US Population Screened by Mass Spectrometry
37. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: A prospective cohort study
38. Dynamic electromyographic analysis of trunk musculature in professional golfers
39. Association Between Simian Virus 40 DNA and Lymphoma in the United Kingdom
40. Are patellofemoral pain and quadriceps femoris muscle torque associated with locomotor function?
41. Report of the NAFO Joint Fisheries Commission-Scientific Council Working Group on Risk-Based Management Strategies (WG-RBMS)
42. Bevindingen bij het post-poliomyelitissyndroom: Spierzwakte van het onder- en bovenbeen als oorzaak van late pijn na poliomyelitis
43. Lopen met een stijf been bij spastische parese:: een onderzoek naar spieractiviteit van de M. quadriceps en de hamstrings
44. Genome Sequencing to Discover Drivers of Clonal Expansion in Smoldering Multiple Myeloma
45. Single-Cell RNA Sequencing of Circulating Tumor Cells in Precursor Myeloma Patients Reveals Mechanisms of Disease Dissemination
46. High-Throughput Plasma Proteomics to Define the Precursor Multiple Myeloma Proteome and Identify Candidate High-Risk Disease Biomarkers of Progression
47. Large-Scale Characterization and Functional Assessment of Adaptive Immunity in Patients with MGUS and SMM Reveals Significant Defects
48. Effectiveness of the use of constraint induced movement therapy on the upper extremities of children diagnosed with hemiplegic cerebral palsy
49. When worlds collide: comments from a barrister
50. If it doesn't show: is it there? Litigating chronic exposure to low-level carbon monoxide emissions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.